EFFICACY AND SAFETY OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: 36-MONTH RESULTS FROM THE RANDOMIZED H2304 STUDY

被引：0
|
作者：
Saliba, F. [1 ]
Duvoux, C. [2 ]
Durand, F. [3 ]
Neau-Cransac, M. [4 ]
Hardwigsen, J. [5 ]
Pageaux, G. [6 ]
Di Giambattista, F. [7 ]
机构：
[1] Hop Paul Brousse, Villejuif, France
[2] Hop Henri Mondor, F-94010 Creteil, France
[3] Hop Beaujon, Clichy, France
[4] Hop Pellegrin, F-33076 Bordeaux, France
[5] Hop Conception, Marseille, France
[6] Hop St Eloi, Montpellier, France
[7] Novartis Pharma SAS, Rueil Malmaison, France
来源：
TRANSPLANT INTERNATIONAL | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
74
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study
    Jeng, Long-Bin
    Lee, Sung Gyu
    Soin, Arvinder Singh
    Lee, Wei-Chen
    Suh, Kyung-Suk
    Joo, Dong Jin
    Uemoto, Shinji
    Joh, Jaewon
    Yoshizumi, Tomoharu
    Yang, Horng-Ren
    Song, Gi-Won
    Lopez, Patricia
    Kochuparampil, Jossy
    Sips, Carole
    Kaneko, Shuhei
    Levy, Gary
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (06) : 1435 - 1446
  • [22] SAFETY AND EFFICACY OF EARLY USE OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS VS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA
    Schlitt, H. J.
    Nashan, B.
    Schemmer, P.
    Pascher, A.
    Klein, C. G.
    Neumann, U.
    Kroeger, I.
    Wimmer, P.
    Braun, F.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 25 - 25
  • [23] Efficacy and Safety of Everolimus With Low-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Randomized Study
    Qazi, Y.
    Shaffer, D.
    Kaplan, B.
    Kim, D.
    Luan, F.
    Peddi, V.
    Shihab, F.
    Tomlanovich, S.
    Yilmaz, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    TRANSPLANTATION, 2014, 98 : 80 - 80
  • [24] Efficacy and Safety of Everolimus With Low-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Randomized Study
    Qazi, Y.
    Shaffer, D.
    Kaplan, B.
    Kim, D.
    Luan, F.
    Peddi, V.
    Shihab, F.
    Tomlanovich, S.
    Yilmaz, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 80 - 80
  • [25] EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS: 12 MONTH RESULTS OF A RANDOMIZED, CONTROLLED STUDY IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS
    Nevens, F.
    De Carlis, L.
    Metselaar, H.
    Saliba, F.
    Beckebaum, S.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Fung, J.
    Jiang, H.
    Junge, G.
    De Simone, P.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S551 - S552
  • [26] Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of 2 Randomized Controlled Trials
    Lee, Sung-Gyu
    Jeng, Long-Bin
    Saliba, Faouzi
    Soin, Arvinder Singh
    Lee, Wei-Chen
    De Simone, Paolo
    Nevens, Frederik
    Suh, Kyung-Suk
    Fischer, Lutz
    Joo, Dong Jin
    Fung, John
    Joh, Jae-Won
    Kaido, Toshimi
    Grant, David
    Meier, Matthias
    Rauer, Barbara
    Sips, Carole
    Kaneko, Shuhei
    Levy, Gary
    TRANSPLANTATION, 2021, 105 (07) : 1564 - 1575
  • [27] Efficacy and Safety of Everolimus with Reduced-Exposure Tacrolimus and Corticosteroid Withdrawal in De Novo Pediatric Renal Transplant Recipients: 12-Month Results from the CRADLE Study
    Ettenger, R.
    Tonshoff, B.
    Tedesco, H.
    Dello Strologo, L.
    Marks, S.
    Pape, L.
    Martzloff, E.
    Rauer, B.
    Ng, J.
    Lopez, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 407 - 408
  • [28] EVEROLIMUS WITH REDUCED TACROLIMUS PROVIDES IMPROVED RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS: A MELD SCORE SUBGROUP ANALYSES FROM THE RANDOMISED-CONTROLLED H2304 STUDY AT MONTH 12 AND 24
    Saliba, Faouzi
    Fischer, Lutz
    De Simone, Paolo
    Dong, Gaohong
    Escrig, Cesar
    Lopez, Patricia
    TRANSPLANT INTERNATIONAL, 2015, 28 : 199 - 200
  • [29] Comparable efficacy-safety and better renal function with everolimus and reduced-exposure tacrolimus versus standard-exposure tacrolimus in liver transplant recipients: H2304 and H2307 pooled analysis
    Levy, G.
    Lee, S. G.
    Jeng, L. -B
    Soin, A. S.
    Lee, W. -C
    De Simone, P.
    Nevens, F.
    Suh, K. -S
    Fischer, L.
    Joo, D. J.
    Fung, J.
    Joh, J. -W
    Kaido, T.
    Grant, D.
    Meier, M.
    Sips, C.
    Kaneko, S.
    Saliba, F.
    TRANSPLANTATION, 2019, 103 (08) : 36 - 36
  • [30] Design and Baseline Data from Hephaistos Study Evaluating Efficacy and Safety of Early Initiation of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients
    Nashan, Bjorn
    Schemmer, Peter
    Braun, Felix
    Dworak, Markus
    Wimmer, Peter
    Schlitt, Hans
    TRANSPLANTATION, 2015, 99 : 214 - 215
12345